WEEKEND OBSERVATION
3D bioprinting of functional meniscus constructs with anisotropic properties using meniscus-derived bioink for knee meniscus regeneration.
No routine new-paper batch was visible for this field on 2026-07-26; this is a weekend observation of the latest visible primary record from 2026-07-24, not a new-publication claim for the observation date.
Meniscal injuries frequently result in progressive degeneration of the knee joint, primarily due to the tissue's limited intrinsic healing capacity. To address this clinical challenge, we developed an anisotropic meniscus scaffold using three-dimensional (3D) bioprinting technology to promote functional regeneration. In this study, the scaffold was fabricated via 3D bioprinting, employing a composite of polyurethane and polycaprolactone polymers, meniscus derived decellularized extracellular matrix bioink, and mesenchymal stem cells (MSCs).In vitro, the bioprinted constructs, incorporating tissue-derived bioinks with region-specific stiffness, facilitated the differentiation of MSCs and extracellular matrix deposition in a manner that recapitulated the native anisotropic architecture of the meniscus.In vivo, the constructs demonstrated excellent chondroprotective effects and supported neo-meniscus formation in a canine model at 12 and 24 weeks post-implantation. These findings suggest that the engineered 3D bioprinted meniscus scaffold holds strong potential for clinical application in meniscal repair and regeneration.
Evidence boundary: 这是体外与犬模型证据,不是人体临床疗效;纳入依据是活细胞、生物墨水与组织工程目标。
Community pulse · verified public sources
Social Network Radar
2026-07-26—2026-07-26. Items come from public APIs and pass original-link and Beijing-time window checks. They indicate public attention and discussion, not paper quality, clinical effectiveness, or scientific consensus.
RRID Robot @rridrobot.bsky.social
Immune-Responsive Bioinks Enable Vision-Guided in Situ Robotic Bioprinting to Accelerate Diabetic Wound Healing
RRIDs were included in this in Advanced Functional Materials paper. RRIDs improve reproducibility in scientific research. #accelerateopenscience #methodsmatter #reproducibility
Safety In Numbers @safetyinnumbers.bsky.social
Japan Clears First iPSC Therapies for Clinical Use
Just this year, Japan conditionally approved a special iPSC therapy to regrow the heart after major heart attack, and treatment for Parkinson's. themedicinemaker.com/issues/2026/... In contrast, bioprinting organs is still a ways off, alas.